During the past decade, Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 28 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 21 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna" #1 sponsor was "Eli Lilly and Company" with 13 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored, "Pfizer" with 7 trials sponsored and "Amgen" with 7 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna" are "Psoriasis" (7 trials), "Type 2 Diabetes Mellitus" (6 trials), "Arthritis, Psoriatic" (4 trials), "Dermatitis, Atopic" (4 trials) and "Atopic Dermatitis" (3 trials). Many other conditions were trialed in "Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna" in a lesser frequency.

Most popular intervention types in "Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna" are "Drug" (51 trials), "Biological" (4 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Guselkumab" (5 trials), "Atezolizumab" (4 trials), "Tirzepatide" (4 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna" are 52 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna". undefined are not yet recruiting, 9 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".